Teva Reports Second Quarter 2008 Results - Record Quarterly Sales of $2,823 Million
- Details
- Category: Financial
![Teva Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd.](http://www.worldpharmanews.com/images/stories/logo/teva.gif)
IAFF Launches Smoking Cessation Campaign with Pfizer
- Details
- Category: Pfizer
![Pfizer Inc. Pfizer Inc.](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
Boehringer Ingelheim continued to post strong growth in local currencies in the first half of 2008
- Details
- Category: Boehringer Ingelheim
![Boehringer Ingelheim Boehringer Ingelheim](http://www.worldpharmanews.com/images/stories/logo/boehringeringelheim.gif)
Grindeks profit reaches 5 million lats in the first half of 2008
- Details
- Category: Financial
![JSC Grindeks JSC Grindeks](http://www.worldpharmanews.com/images/stories/logo/grindex.gif)
PLIVA Announces H1 2008 Results
- Details
- Category: Financial
![PLIVA d.d. PLIVA d.d.](http://www.worldpharmanews.com/images/stories/logo/pliva.gif)
Nycomed's preclinical anti-cancer program sold to Bayer Schering Pharma
- Details
- Category: Nycomed
![Nycomed Nycomed](http://www.worldpharmanews.com/images/stories/logo/nycomed.gif)
Lipitor 80 mg Reduced the Risk of Heart Attack and Stroke
- Details
- Category: Pfizer
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
More Pharma News ...
- Closure of the tipranavir trials SPRING and TICINO
- Novo Nordisk employee suspended after being charged with insider trading
- First interleukin-6 inhibitor (IL-6) to offer new therapeutic option for rheumatoid arthritis
- Significant blood pressure reductions seen with Exforge across difficult-to-treat groups
- GlaxoSmithKline and the Harvard Stem Cell Institute announce a unique collaboration
- Nexavar Approved for Treatment of Liver Cancer in China
- Nexavar Study Demonstrates Significant Improvement in Overall Survival